The cytokine interleukin (IL)-12 is bound by a heterodimeric receptor and mediates a range of immunological activities, in particular, favouring the development of uncommitted T cells to the Th1 phenotype. Genes encoding elements of the IL-12 pathway are therefore good candidates for mediating susceptibility or resistance to a range of immune disorders, including Type I diabetes. We made a systematic search for variants in the human gene encoding the low-affinity IL-12 receptor, IL12RB1. Four single-nucleotide polymorphisms and two microsatellite polymorphisms were defined. We also tested these IL12RB1 alleles for involvement in Type I diabetes susceptibility, testing 131 families. Although suggestive evidence for linkage to a susceptibility gene was found, none of the IL12RB1 variants we defined demonstrated preferential transmission in these families.
Introduction
Immune responses are regulated by a balance of Th1 and Th2 cytokines. CD4+T helper T cells are conditioned by interleukin 12 (IL-12) to differentiate along the Th1 pathway.
1 IL-12 also acts together with IL-2 and TNF-a to induce IFN-g expression in NK cells and acts on both CD8+T cells and NK cells to enhance their cytotoxicity. 2 Administration of IL-12 into diabetes-prone NOD mice has been shown to induce premature onset of Type I diabetes (T1D). 3 IL-12 is a heterodimeric cytokine produced by activated monocytes and B cells. The biological activities of IL-12 are mediated through high-affinity binding to IL-12 receptors (IL-12R), which are composed of two subunits, termed IL-12Rb1 and IL-12Rb2. 4 ,5 IL-12Rb1 is approximately 100 kDa and is encoded by the IL12RB1 gene on human chromosome 19p13.1; IL-12Rb2 is approximately 130 kDa, encoded by the IL12RB2 gene on human chromosome 1p31.2.
6,7 IL12RB1 does not contain any cytoplasmic tyrosine residues and binds IL-12 with low (2-5 nM) affinity. In contrast, the cytoplasmic region of IL-12Rb2 contains three tyrosine residues, suggesting an important role for the b2 subunit in IL-12 signal transduction. When both b1 and b2 subunits are coexpressed, the IL-12 receptor complex binds IL-12 with intermediate (5-200 pM) affinity. 6, 7 Recently, we identified a novel IDDM susceptibility locus on chromosome 5q near the gene encoding the IL12p40 subunit (IL12B). 8 To test further the involvement of the IL-12 pathway in susceptibility to T1D, a gene encoding another component of this pathway, IL12RB1, was chosen for analysis. Genetic deficiencies in IL12RB1 have been reported, and these result in severe bacterial infections. 9, 10 While these examples demonstrate the importance of IL12RB1 in resolving infectious diseases, the reported deficiencies are rare and unlikely to be involved in the normal population-based genetic variance in immune responses. Therefore, we have undertaken a systematic search for common genetic polymorphisms in IL12RB1.
Results and discussion
Search for polymorphisms Genetic variants in IL12RB1 were sought by singlestranded conformational polymorphism (SSCP) analysis. All 17 coding exons as well as the 5 0 and 3 0 UTR were amplified (using primers listed in Table 1 ) and tested for variation by SSCP. A total of four single-nucleotide polymorphisms (SNPs) were identified and these were confirmed and characterised by direct sequencing (Table 2) .
Three nonsynonymous polymorphisms were identified: an A-G substitution in exon 7, which resulted in an glutamine to arginine change in the predicted protein. This A-G substitution also destroyed a PvuII restriction site, allowing a simple PCR-based genotyping assay. The two SNPs identified in exon 10 also result in a difference in the encoded protein. The T-C substitution resulted in a methionine to threonine change in the encoded protein, Primers were designed from Genbank entry NM 005535 and AC020904.7 to amplify each of the exons and 5 0 and 3 0 UTR of IL12RB1. PCR products were used subsequently for polymorphism detection by SSCP. In addition, the simple sequence repeats were also amplified to test whether they were polymorphic. (N.B. marker 9b used in the Nla III genotyping assay only.) 
The site of each polymorphism is defined according to its position in Genbank entry NM 005535. Its relative position in the gene, predicted effect (if any) on protein sequence and on restriction enzymes sites are also shown, in addition to D-numbers for polymorphic markers (a complete description of each marker is available at http:// www.gdb.org/). Allele frequencies were estimated after testing 100 unrelated control subjects.
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which also destroyed an Nla III restriction site. The G-C substitution creates an Hpa II restriction site and results in a glycine to arginine change. The allele frequencies of these sequence variants did not reach significance (Table 2 ). These amino-acid substitutions occur in the transmembrane region of the IL-12RB1 protein; what effect, if any, these substitutions have on the protein function and/or structure remains to be determined. A C-T substitution identified in the 3 0 UTR results in the destruction of an Ava I restriction site. The apparent paucity of variants in the IL-12Rb1 protein contrasts with its diversity across species. Comparison of the human and mouse proteins reveals only a 54% amino-acid sequence identity for the IL-12Rb1 subunit, suggesting that receptor function may be sustained despite the wide variation in primary structure. This observation is similar to that found for IL12B, which also varies widely across species yet has no commonly occurring proteincoding alleles. 11 In addition to these SNPs, we defined two simple sequence length polymorphisms. The first, designated D19S1195, was a (TTTA) n tetranucleotide repeat in intron 1, for which the Genbank entry has 11 repeats. The second, D19S1200, was a trinucleotide (AGG) n repeat in the 5 0 UTR, which was repeated 16 times in the Genbank sequence. These markers varied in the number of repeats (Table 2 ) and so could be useful as microsatellite markers in genotyping DNA samples for family studies.
Three additional simple sequence tandem repeats identified in the Genbank sequence were found not to be polymorphic; (CCAT) 9 in intron 3, (ATTC) 7 in the 3 0 UTR and (AAAT) 8 also in the 3 0 UTR of the Genbank sequence.
SNP database searching A search was also conducted through the SNP database at http://www.ncbi.nlm.nih.gov/SNP/. The IL12RB1 sequence was aligned and compared to sequences submitted into the database. Using this approach, two putative SNPs, one in the 5 0 untranslated region of exon 1 (C/T) and one in exon 11 (C/T), were identified. The C/ T substitution in exon 11 altered a Taq I site (TCGA), which was used in an assay to screen 100 individuals for the presence of this potential SNP. The exon 1 substitution did not alter an enzyme recognition site, therefore, SSCP and direct sequencing was performed. Neither of these polymorphisms could be confirmed, suggesting either that the polymorphisms were because of sequencing errors or are present at a low frequency in the population.
Test for linkage
To test whether IL12RB1 may be involved in susceptibility to human T1D, we typed 148 affected sib pairs for markers on chromosome 19p13.1-13.2, to which we had mapped IL12RB1 by radiation hybrid analysis (data not shown). A LOD score of 1.6 was obtained with an adjacent marker, D19S226, suggestive of linkage to a susceptibility gene ( Transmission disequilibrium test of IL12RB1 polymorphisms All 131 Type I diabetic multiplex families were typed for the polymorphic IL12RB1 markers identified above. Transmission of these alleles to affected sib pairs was evaluated using TDT. Although allele 17182T and 17220G of exon 10 were transmitted at 54.8 and 55.5%, respectively, neither reached statistical significance (P ¼ 0.068 and 0.056, respectively). Random transmission of alleles of all other variants to affected offspring was observed (Table 4 ). These data suggest that IL12RB1 is not the gene showing linkage to T1D on chromosome 19p13.1-13.2. Alternatively, other polymorphisms not in linkage disequilibrium (LD) with the alleles tested here may be important; if so, these as-yet undefined variants are unlikely to be in exons of IL12RB1 and would therefore have to exert their effects by regulation of gene expression. This was found for the IL12B gene, which also lacks commonly occurring protein variants. The number of affected sibs pairs (ASP) sharing 2, 1 or no alleles are shown from their genotypes at four microsatellite loci linked to IL12Rb1. Single-point maximised LOD scores (MLS) were calculated. 24 Data were also stratified for sibs sharing HLA haplotypes identical-by-decent and differing at the HLA loci (mismatched).
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Linkage disequilibrium of IL12RB1 polymorphisms The extent of LD between the IL12RB1 alleles defined here would have implications for testing any of these polymorphisms for association with other immune disorders. Therefore, genotyping data from the parents of the T1D families were used to reconstruct IL12RB1 haplotypes and assess LD at this locus. The amino acid changing SNP, D19S1196, was chosen as the anchor polymorphism and the statistic |D 0 | was calculated for LD between this SNP and each of the other polymorphisms, similar to the approach Reich et al 16 used to define LD at 19 genes. From Figure 1 , it may be seen that LD decays quickly across IL12RB1. The 3 0 UTR SNP shows D 0 o0.5, as does the intron 1 allele. Even the two exon 10 SNPs do not show complete LD: the value of D 0 between these SNPs is only 0.66. Of the 19 genes studied by Reich et al, 16 the only example of comparably rapid decay of LD was in another cytokine receptor gene, IL17R. Our results suggest that association studies testing LD of disease susceptibility loci with IL12RB1 should use at least 3 markers: at the 5 0 end of the gene, the exon 7 and 3 0 UTR SNPs. 16 
Concluding remarks
Many studies of IL-12 have demonstrated its importance in driving Th1 cell development. In some cases, these Th1 responses may result in autoimmune disease. For example, Th1 cells are the main initiators of insulitis, the lymphocytic infiltrate that may be observed in pancreatic islets prior to diabetes development. 17, 18 With the demonstration of IL-12 in T1D development in animal models and the identification of IL12B as a susceptibility locus in humans, 8, 19 and of differential IL-12 gene expression in humans 8, 19 and mice, 20 other genes in the IL-12 pathway also become candidates for involvement in T1D. We successfully applied SSCP screening to identify genetic polymorphisms within the IL12RB1 gene. Three of these variants would result in a change to the predicted protein. Although the alleles we defined here were not transmitted preferentially 
Transmission (T) vs no transmission (NT) of an allele from parent to affected offspring is measured as a percentage of transmission (%T).
The n values represent the number of each allele observed. Only P values o0.1 are shown. Figure 1 LD of IL12RB1 polymorphisms. The extent of LD between the exon 7 SNP and each of five key IL12RB1 polymorphisms was calculated using the D 0 statistic as described. 19 The distance of each polymorphism from the exon 7 SNP is shown and each polymorphism is indicated on the graph.
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within families of T1D subjects, they may be useful for testing involvement of IL12RB1 in other immune disorders.
Methods

Subjects
The study cohort consisted of DNA from anonymous Caucasoid donors from the Melbourne community. In all, 131 Type I diabetic multiplex families together with genotypes for the HLA-A, -B and -DR alleles were obtained from the British Diabetic Association (BDA) providing a total of 148 affected sib pairs.
Genomic organisation and primer design
In order to search for mutations in the IL12RB1 gene, each exon and the flanking exon-intron boundary sequence was analysed individually. The exon/intron boundaries for the IL12RB1 gene were elucidated by comparison of the genomic sequence against the mRNA sequence. In total, the IL12RB1 gene was found to contain 17 exons varying in size from 31 to 238 bp in length.
PCR primers were designed using the Whitehead Primer3 program. 21 Primers were designed to amplify all exon and exon-intron boundary sequences for SSCP analysis. Primers were also designed to amplify five repeat elements that were identified in the genomic sequence (Table 1) .
PCR and SSCP analysis
Mutation detection was performed using single-stranded conformational polymorphism (SSCP) analysis. PCR amplification was as follows: 941C for 5 min; then 35 cycles each consisting of denaturation at 941C, 30 s, annealing at 581C, 30 s and extension at 721C, 60 s; followed by 721C for 9 min. The PCR cocktail contained 100 ng genomic DNA, 100 mM dNTP, 2.5 ng of 5 0 and 3 0 oligonucleotide primers (Table 1) , 1 Â Ci a-32 P dNTP and 0.25 m U Taq polymerase (GibcoBRL) in 1 Â PCR buffer with 2 mM MgCl 2 in a 10 ml final reaction volume. Following amplification, 40 ml of loading buffer (98% formamide) was added to the PCR product and the samples denatured for 5 min at 951C and immediately plunged onto ice. Two microlitre of this mixture was then loaded onto an 8% nondenaturing polyacrylamide gel (49 : 1) at 1000 V for 6 h at 41C. Following electrophoresis, the polyacrylamide gel was transferred to blotting paper and exposed to X-ray film (Kodak) for 16 h at À701C. Only one assay condition was used for routine SSCP screening because testing several other conditions in early experiments did not improve the sensitivity of polymorphism detection (data not shown) Sequencing Single-nucleotide polymorphisms identified by SSCP were confirmed and characterised by sequencing. DNA from individuals presenting different SSCPs were reamplified to a total PCR volume of 60 ml and PCR products gel purified using the QIAgen kit according to the manufacturer's instructions. The purified DNA (90 ng) was sequenced using the ABI PRISM 
Genotyping
The simple sequence repeats, (AGG) n of the 5 0 UTR, (TTTA) n of intron 1, (CCAT) n of intron 3 and (ATTC) n and (AAAT) n of the 3 0 UTR were analysed by PCR as described above. Analysis of the single-nucleotide polymorphisms (SNPs) in exons 7 and 10 and the 3 0 UTR of the IL12RB1 gene was performed by PCR amplification as described above without the a-32 P isotope. The PCR product was digested with one of the following restriction enzymes at 1 U/sample; Pvu II (11014 A/G), Nla III (17182 T/C), Hpa II (17220 G/C) and Ava I (27334 C/T) for 5 h at 371C ( Table 2 ). The final product was analysed by electrophoresis on an agarose-1000 gel with 0.5 mg/ml ethidium bromide.
Genetic analysis
Multipoint linkage analysis was performed using the MAPMAKER/SIBS program. 22 Transmission of microsatellite marker alleles and SNP alleles were assessed from heterozygous parents to affected offspring by applying the transmission disequilibrium test (TDT) described by Spielman 23 using the Genome Analysis System program (GAS ver 2.0). 24 The extent of linkage disequilibrium of an allele with T1D was quantitated in terms of percentage of transmission, which is the number of times that an allele is transmitted from heterozygous parents to affected offspring, divided by the number of transmissions expressed as a percentage.
Abbreviations IL, interleukin; IL12RB1, IL12 receptor beta 1 subunit; LD, linkage disequilibrium; Th1, T helper type 1; Th2, T helper type 2; T1D, Type I diabetes; SSCP, single-stranded conformational polymorphism; SNP, single-nucleotide polymorphism; TDT, transmission disequilibrium test.
